Funding

Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Laboratory receives funding from these sources.

Grants

Investigator & Role Grant Title Funding Source Duration
Nilufer Ertekin-Taner, M.D., Ph.D., multiple principal investigators A Systems Approach to Targeting Innate Immunity in AD (U01 AG046139-06 Multiple PD/PI Co-operative Agreement at University of Florida) National Institute on Aging 09/2018 - 08/2023
Nilufer Ertekin-Taner, M.D., Ph.D., principal investigator Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD (R01 AG061796) National Institute on Aging 09/2018 - 04/2023
Nilufer Ertekin-Taner, M.D., Ph.D., site principal investigator Molecular Characterization and Validation of Gender Differences in Alzheimer's Disease Pathogenesis (RF1 AG054014 PI Bin Zhang) National Institute on Aging 09/2016 - 08/2021
Nilufer Ertekin-Taner, M.D., Ph.D., multiple principal investigator Integrative translational discovery of vascular risk factors in aging and dementia (RF1 AG051504-01S2 Ertekin-Taner, Guojun Bu) National Institute on Aging 09/2017 - 08/2020
Nilufer Ertekin-Taner, M.D., Ph.D., multiple principal investigators Integrative translational discovery of vascular risk factors in aging and dementia (RF1 AG051504 Ertekin-Taner, Guojun Bu) National Institute on Aging 09/2015 - 08/2020
Nilufer Ertekin-Taner, M.D., Ph.D., principal investigator Florida Consortium for African-American Alzheimer's Disease Studies (FCA3DS) Florida Dept. of Health's Ed and Ethel Moore Alzheimer's Disease Research Program 02/2017 - 01/2019